Synthesis of 2-(3-Substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo[3.2.1]octanes and 2α-(3-Substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo[3.2.1]oct-2-enes as Potential Muscarinic Agonists View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1992-11

AUTHORS

David J. Triggle, Yong Wha Kwon, Philip Abraham, M. Abdur Rahman, F. Ivy Carroll

ABSTRACT

Radioligand binding affinities of seven muscarinic receptor ligands which possess an oxadiazole ring side chain have been determined in rat heart, rat brain, and m1- or m3-transfected CHO cell membrane preparations to determine the selectivity for subtypes of muscarinic receptor. The ratios of binding constants in brain membranes were measured as an indicator of potential agonist activity against [3H]QNB and [3H]Oxo-M. These muscarinic ligands did not discriminate the subtypes of muscarinic receptors. Six muscarinic ligands which have a 3-amino- or 3-methyl-1,2,4-oxadiazol-5-yl groups attached to the 8-methyl-8-azabicyclo[3.2.1]oct-2-ene or 8-methyl-8-azabicyclo[3.2.1]octane head group show binding constants between 2.04 x 10−6 and 1.79 x 10−5M in rat heart, rat brain, and m1- or m3-transfected CHO cell membrane preparations. 1-Methyl-2-[3-amino-1,2,4-oxadiazol-5-yl]piperidine shows low binding constants of approximately 10−4M in rat heart and rat brain. (1R,5S)-2-[3-Amino-1,2,4-oxadiazol-5-yl]-8-methyl-8-azabicyclo-[3.2.1]oct-2-ene [(1R,5S)-17] was the most active compound. More... »

PAGES

1474-1479

Identifiers

URI

http://scigraph.springernature.com/pub.10.1023/a:1015871131913

DOI

http://dx.doi.org/10.1023/a:1015871131913

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037932584

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/1475236


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Binding, Competitive", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bridged Bicyclo Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CHO Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cricetinae", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oxadiazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Parasympathomimetics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radioligand Assay", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Muscarinic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transfection", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Biochemical Pharmacology, School of Pharmacy, State University of New York at Buffalo, 14260, Buffalo, New York", 
          "id": "http://www.grid.ac/institutes/grid.273335.3", 
          "name": [
            "Department of Biochemical Pharmacology, School of Pharmacy, State University of New York at Buffalo, 14260, Buffalo, New York"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Triggle", 
        "givenName": "David J.", 
        "id": "sg:person.0614640423.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614640423.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biochemical Pharmacology, School of Pharmacy, State University of New York at Buffalo, 14260, Buffalo, New York", 
          "id": "http://www.grid.ac/institutes/grid.273335.3", 
          "name": [
            "Department of Biochemical Pharmacology, School of Pharmacy, State University of New York at Buffalo, 14260, Buffalo, New York"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kwon", 
        "givenName": "Yong Wha", 
        "id": "sg:person.01242562137.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242562137.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, P.O. Box 12194, 27709, North Carolina", 
          "id": "http://www.grid.ac/institutes/grid.62562.35", 
          "name": [
            "Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, P.O. Box 12194, 27709, North Carolina"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Abraham", 
        "givenName": "Philip", 
        "id": "sg:person.01272374045.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272374045.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, P.O. Box 12194, 27709, North Carolina", 
          "id": "http://www.grid.ac/institutes/grid.62562.35", 
          "name": [
            "Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, P.O. Box 12194, 27709, North Carolina"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rahman", 
        "givenName": "M. Abdur", 
        "id": "sg:person.01112307524.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112307524.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, P.O. Box 12194, 27709, North Carolina", 
          "id": "http://www.grid.ac/institutes/grid.62562.35", 
          "name": [
            "Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, P.O. Box 12194, 27709, North Carolina"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carroll", 
        "givenName": "F. Ivy", 
        "id": "sg:person.01007744060.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007744060.52"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00431470", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030066972", 
          "https://doi.org/10.1007/bf00431470"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1992-11", 
    "datePublishedReg": "1992-11-01", 
    "description": "Radioligand binding affinities of seven muscarinic receptor ligands which possess an oxadiazole ring side chain have been determined in rat heart, rat brain, and m1- or m3-transfected CHO cell membrane preparations to determine the selectivity for subtypes of muscarinic receptor. The ratios of binding constants in brain membranes were measured as an indicator of potential agonist activity against [3H]QNB and [3H]Oxo-M. These muscarinic ligands did not discriminate the subtypes of muscarinic receptors. Six muscarinic ligands which have a 3-amino- or 3-methyl-1,2,4-oxadiazol-5-yl groups attached to the 8-methyl-8-azabicyclo[3.2.1]oct-2-ene or 8-methyl-8-azabicyclo[3.2.1]octane head group show binding constants between 2.04 x 10\u22126 and 1.79 x 10\u22125M in rat heart, rat brain, and m1- or m3-transfected CHO cell membrane preparations. 1-Methyl-2-[3-amino-1,2,4-oxadiazol-5-yl]piperidine shows low binding constants of approximately 10\u22124M in rat heart and rat brain. (1R,5S)-2-[3-Amino-1,2,4-oxadiazol-5-yl]-8-methyl-8-azabicyclo-[3.2.1]oct-2-ene [(1R,5S)-17] was the most active compound.", 
    "genre": "article", 
    "id": "sg:pub.10.1023/a:1015871131913", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2445330", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1094644", 
        "issn": [
          "0724-8741", 
          "1573-904X"
        ], 
        "name": "Pharmaceutical Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "keywords": [
      "rat brain", 
      "rat heart", 
      "muscarinic receptors", 
      "cell membrane preparations", 
      "muscarinic ligands", 
      "potential agonist activity", 
      "muscarinic receptor ligands", 
      "muscarinic agonists", 
      "agonist activity", 
      "brain membranes", 
      "membrane preparations", 
      "receptor ligands", 
      "brain", 
      "subtypes", 
      "heart", 
      "potential muscarinic agonists", 
      "receptors", 
      "M1", 
      "group", 
      "agonists", 
      "active compounds", 
      "activity", 
      "ligands", 
      "preparation", 
      "ring side chain", 
      "indicators", 
      "affinity", 
      "membrane", 
      "ratio", 
      "compounds", 
      "synthesis", 
      "side chains", 
      "selectivity", 
      "chain", 
      "head groups", 
      "constants", 
      "oxadiazole ring side chain", 
      "m3-transfected CHO cell membrane preparations", 
      "CHO cell membrane preparations"
    ], 
    "name": "Synthesis of 2-(3-Substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo[3.2.1]octanes and 2\u03b1-(3-Substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo[3.2.1]oct-2-enes as Potential Muscarinic Agonists", 
    "pagination": "1474-1479", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037932584"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1023/a:1015871131913"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "1475236"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1023/a:1015871131913", 
      "https://app.dimensions.ai/details/publication/pub.1037932584"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:07", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_244.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1023/a:1015871131913"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/a:1015871131913'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/a:1015871131913'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/a:1015871131913'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/a:1015871131913'


 

This table displays all metadata directly associated to this object as RDF triples.

190 TRIPLES      22 PREDICATES      80 URIs      71 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1023/a:1015871131913 schema:about N1b6e157cab8848ce9fb4820a83ba75ee
2 N1d7099acf5f14106a7d2a4411fd76832
3 N253f2db8728d44a6b898d545feda6bfb
4 N32b17a08d8704df3ab7f8369be928b2d
5 N4427fb6c988149a098daf0fa444fb2d9
6 N50e2a37e58274c549a25040d5db33389
7 N50f9172ff18549b7b453df47681a28e6
8 N64b3f6be3baa4e3b88453c1953b0de62
9 N6f05def5a507460781287370c103ee9e
10 N7e93e1d9a4f94375b5797fef31a6ffce
11 Nb570b94a8da54704bf506602c175db52
12 Nd7859623e1564bba9f7f3333b2e5e4c8
13 Nd9706517334a477392e404caad85ecd2
14 anzsrc-for:11
15 anzsrc-for:1109
16 schema:author N9a62ccdedf9d488893fb2c27fcc3026e
17 schema:citation sg:pub.10.1007/bf00431470
18 schema:datePublished 1992-11
19 schema:datePublishedReg 1992-11-01
20 schema:description Radioligand binding affinities of seven muscarinic receptor ligands which possess an oxadiazole ring side chain have been determined in rat heart, rat brain, and m1- or m3-transfected CHO cell membrane preparations to determine the selectivity for subtypes of muscarinic receptor. The ratios of binding constants in brain membranes were measured as an indicator of potential agonist activity against [3H]QNB and [3H]Oxo-M. These muscarinic ligands did not discriminate the subtypes of muscarinic receptors. Six muscarinic ligands which have a 3-amino- or 3-methyl-1,2,4-oxadiazol-5-yl groups attached to the 8-methyl-8-azabicyclo[3.2.1]oct-2-ene or 8-methyl-8-azabicyclo[3.2.1]octane head group show binding constants between 2.04 x 10−6 and 1.79 x 10−5M in rat heart, rat brain, and m1- or m3-transfected CHO cell membrane preparations. 1-Methyl-2-[3-amino-1,2,4-oxadiazol-5-yl]piperidine shows low binding constants of approximately 10−4M in rat heart and rat brain. (1R,5S)-2-[3-Amino-1,2,4-oxadiazol-5-yl]-8-methyl-8-azabicyclo-[3.2.1]oct-2-ene [(1R,5S)-17] was the most active compound.
21 schema:genre article
22 schema:inLanguage en
23 schema:isAccessibleForFree false
24 schema:isPartOf N2aeadd2544cb466cb9bff5b6bea6fa01
25 N47066ac43bd0426d9390e073372a4201
26 sg:journal.1094644
27 schema:keywords CHO cell membrane preparations
28 M1
29 active compounds
30 activity
31 affinity
32 agonist activity
33 agonists
34 brain
35 brain membranes
36 cell membrane preparations
37 chain
38 compounds
39 constants
40 group
41 head groups
42 heart
43 indicators
44 ligands
45 m3-transfected CHO cell membrane preparations
46 membrane
47 membrane preparations
48 muscarinic agonists
49 muscarinic ligands
50 muscarinic receptor ligands
51 muscarinic receptors
52 oxadiazole ring side chain
53 potential agonist activity
54 potential muscarinic agonists
55 preparation
56 rat brain
57 rat heart
58 ratio
59 receptor ligands
60 receptors
61 ring side chain
62 selectivity
63 side chains
64 subtypes
65 synthesis
66 schema:name Synthesis of 2-(3-Substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo[3.2.1]octanes and 2α-(3-Substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo[3.2.1]oct-2-enes as Potential Muscarinic Agonists
67 schema:pagination 1474-1479
68 schema:productId N8d48bc63b4da41c2a50f92626e6e1913
69 Neb09930974be43928f07baaaa90b3866
70 Nf6254ec679f94e6fb99449c9d8a4969b
71 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037932584
72 https://doi.org/10.1023/a:1015871131913
73 schema:sdDatePublished 2021-12-01T19:07
74 schema:sdLicense https://scigraph.springernature.com/explorer/license/
75 schema:sdPublisher N2a0789fcd9e3424cae68149312eda771
76 schema:url https://doi.org/10.1023/a:1015871131913
77 sgo:license sg:explorer/license/
78 sgo:sdDataset articles
79 rdf:type schema:ScholarlyArticle
80 N0e8bdc421f194bba921c8b2505ad424d rdf:first sg:person.01242562137.96
81 rdf:rest Ne3a59b1811fc41529a327c275c6f70c5
82 N1952a41951194437b08087be15192bed rdf:first sg:person.01007744060.52
83 rdf:rest rdf:nil
84 N1b6e157cab8848ce9fb4820a83ba75ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Binding, Competitive
86 rdf:type schema:DefinedTerm
87 N1d7099acf5f14106a7d2a4411fd76832 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Bridged Bicyclo Compounds
89 rdf:type schema:DefinedTerm
90 N253f2db8728d44a6b898d545feda6bfb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Brain
92 rdf:type schema:DefinedTerm
93 N2a0789fcd9e3424cae68149312eda771 schema:name Springer Nature - SN SciGraph project
94 rdf:type schema:Organization
95 N2aeadd2544cb466cb9bff5b6bea6fa01 schema:volumeNumber 9
96 rdf:type schema:PublicationVolume
97 N32b17a08d8704df3ab7f8369be928b2d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Receptors, Muscarinic
99 rdf:type schema:DefinedTerm
100 N4427fb6c988149a098daf0fa444fb2d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Myocardium
102 rdf:type schema:DefinedTerm
103 N47066ac43bd0426d9390e073372a4201 schema:issueNumber 11
104 rdf:type schema:PublicationIssue
105 N50e2a37e58274c549a25040d5db33389 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Parasympathomimetics
107 rdf:type schema:DefinedTerm
108 N50f9172ff18549b7b453df47681a28e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Cricetinae
110 rdf:type schema:DefinedTerm
111 N580a17d98d5b45ba9936fee94b7a3067 rdf:first sg:person.01112307524.75
112 rdf:rest N1952a41951194437b08087be15192bed
113 N64b3f6be3baa4e3b88453c1953b0de62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Oxadiazoles
115 rdf:type schema:DefinedTerm
116 N6f05def5a507460781287370c103ee9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name CHO Cells
118 rdf:type schema:DefinedTerm
119 N7e93e1d9a4f94375b5797fef31a6ffce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Animals
121 rdf:type schema:DefinedTerm
122 N8d48bc63b4da41c2a50f92626e6e1913 schema:name dimensions_id
123 schema:value pub.1037932584
124 rdf:type schema:PropertyValue
125 N9a62ccdedf9d488893fb2c27fcc3026e rdf:first sg:person.0614640423.08
126 rdf:rest N0e8bdc421f194bba921c8b2505ad424d
127 Nb570b94a8da54704bf506602c175db52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Transfection
129 rdf:type schema:DefinedTerm
130 Nd7859623e1564bba9f7f3333b2e5e4c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Radioligand Assay
132 rdf:type schema:DefinedTerm
133 Nd9706517334a477392e404caad85ecd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Rats
135 rdf:type schema:DefinedTerm
136 Ne3a59b1811fc41529a327c275c6f70c5 rdf:first sg:person.01272374045.69
137 rdf:rest N580a17d98d5b45ba9936fee94b7a3067
138 Neb09930974be43928f07baaaa90b3866 schema:name pubmed_id
139 schema:value 1475236
140 rdf:type schema:PropertyValue
141 Nf6254ec679f94e6fb99449c9d8a4969b schema:name doi
142 schema:value 10.1023/a:1015871131913
143 rdf:type schema:PropertyValue
144 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
145 schema:name Medical and Health Sciences
146 rdf:type schema:DefinedTerm
147 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
148 schema:name Neurosciences
149 rdf:type schema:DefinedTerm
150 sg:grant.2445330 http://pending.schema.org/fundedItem sg:pub.10.1023/a:1015871131913
151 rdf:type schema:MonetaryGrant
152 sg:journal.1094644 schema:issn 0724-8741
153 1573-904X
154 schema:name Pharmaceutical Research
155 schema:publisher Springer Nature
156 rdf:type schema:Periodical
157 sg:person.01007744060.52 schema:affiliation grid-institutes:grid.62562.35
158 schema:familyName Carroll
159 schema:givenName F. Ivy
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007744060.52
161 rdf:type schema:Person
162 sg:person.01112307524.75 schema:affiliation grid-institutes:grid.62562.35
163 schema:familyName Rahman
164 schema:givenName M. Abdur
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112307524.75
166 rdf:type schema:Person
167 sg:person.01242562137.96 schema:affiliation grid-institutes:grid.273335.3
168 schema:familyName Kwon
169 schema:givenName Yong Wha
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242562137.96
171 rdf:type schema:Person
172 sg:person.01272374045.69 schema:affiliation grid-institutes:grid.62562.35
173 schema:familyName Abraham
174 schema:givenName Philip
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272374045.69
176 rdf:type schema:Person
177 sg:person.0614640423.08 schema:affiliation grid-institutes:grid.273335.3
178 schema:familyName Triggle
179 schema:givenName David J.
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614640423.08
181 rdf:type schema:Person
182 sg:pub.10.1007/bf00431470 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030066972
183 https://doi.org/10.1007/bf00431470
184 rdf:type schema:CreativeWork
185 grid-institutes:grid.273335.3 schema:alternateName Department of Biochemical Pharmacology, School of Pharmacy, State University of New York at Buffalo, 14260, Buffalo, New York
186 schema:name Department of Biochemical Pharmacology, School of Pharmacy, State University of New York at Buffalo, 14260, Buffalo, New York
187 rdf:type schema:Organization
188 grid-institutes:grid.62562.35 schema:alternateName Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, P.O. Box 12194, 27709, North Carolina
189 schema:name Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, P.O. Box 12194, 27709, North Carolina
190 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...